Delivery Order SPE2DB24D2205-SPE2DB25FDWQB

Award Date 1/7/25
Potential Completion Date 1/29/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medical products to support federal healthcare programs. The contract has an ultimate completion date of January 28, 2025 and does not have a set-aside designation, indicating open...
This is a $4,687.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a completion date of January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed-price contract has an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a $7,030.77 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a ceiling value of $4,530.60 and a completion date of April 5, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medication. This is a firm fixed-price delivery order contract with a completion date of January 17, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a ceiling value of $28,123.08 and a period of performance through January 24, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,030.77 firm fixed-price contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through January 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a $14,061.54 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through January 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a ceiling value of $18,748.72 and an ultimate completion date of January 24, 2025. The contract type is Firm Fixed Price. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWQB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a firm fixed price of $4,687.18 and a completion date of January 29, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/8/25, 9:51 AM